25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

RTALB (RTA Laboratuvarlari Biyolojik) Stock Analysis
Buy, Hold or Sell?

Let's analyze RTA Laboratuvarlari Biyolojik together

I guess you are interested in RTA Laboratuvarlari Biyolojik. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – RTA Laboratuvarlari Biyolojik’s Financial Insights
  • 📈 Technical Analysis (TA) – RTA Laboratuvarlari Biyolojik’s Price Targets

I'm going to help you getting a better view of RTA Laboratuvarlari Biyolojik. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about RTA Laboratuvarlari Biyolojik

I send you an email if I find something interesting about RTA Laboratuvarlari Biyolojik.

1. Quick Overview

1.1. Quick analysis of RTA Laboratuvarlari Biyolojik (30 sec.)










1.2. What can you expect buying and holding a share of RTA Laboratuvarlari Biyolojik? (30 sec.)

How much money do you get?

How much money do you get?
₺0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₺3.84
Expected worth in 1 year
₺4.84
How sure are you?
87.5%

+ What do you gain per year?

Total Gains per Share
₺1.01
Return On Investment
34.0%

For what price can you sell your share?

Current Price per Share
₺2.96
Expected price per share
₺2.6 - ₺3.33
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of RTA Laboratuvarlari Biyolojik (5 min.)




Live pricePrice per Share (EOD)
₺2.96
Intrinsic Value Per Share
₺1.06 - ₺22.60
Total Value Per Share
₺4.89 - ₺26.44

2.2. Growth of RTA Laboratuvarlari Biyolojik (5 min.)




Is RTA Laboratuvarlari Biyolojik growing?

Current yearPrevious yearGrowGrow %
How rich?$47.7m$29.1m$12.2m29.6%

How much money is RTA Laboratuvarlari Biyolojik making?

Current yearPrevious yearGrowGrow %
Making money$747.1k-$992.3k$1.7m232.8%
Net Profit Margin44.0%-38.0%--

How much money comes from the company's main activities?

2.3. Financial Health of RTA Laboratuvarlari Biyolojik (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#419 / 872

Most Revenue
#448 / 872

Most Profit
#146 / 872
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of RTA Laboratuvarlari Biyolojik?

Welcome investor! RTA Laboratuvarlari Biyolojik's management wants to use your money to grow the business. In return you get a share of RTA Laboratuvarlari Biyolojik.

First you should know what it really means to hold a share of RTA Laboratuvarlari Biyolojik. And how you can make/lose money.

Speculation

The Price per Share of RTA Laboratuvarlari Biyolojik is ₺2.96. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of RTA Laboratuvarlari Biyolojik.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in RTA Laboratuvarlari Biyolojik, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₺3.84. Based on the TTM, the Book Value Change Per Share is ₺0.25 per quarter. Based on the YOY, the Book Value Change Per Share is ₺0.40 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₺0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of RTA Laboratuvarlari Biyolojik.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.010.4%0.000.1%0.00-0.1%0.000.0%0.000.0%0.000.0%
Usd Book Value Change Per Share0.010.4%0.010.2%0.010.3%0.010.2%0.000.2%0.000.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.010.4%0.010.2%0.010.3%0.010.2%0.000.2%0.000.1%
Usd Price Per Share0.07-0.28-0.33-0.28-0.45-0.29-
Price to Earnings Ratio1.64--6.27--0.09-3.24-76.20-547.79-
Price-to-Total Gains Ratio5.67-85.49-16.63-37.43-254.16-385.49-
Price to Book Ratio0.74-3.50-6.08-5.85-33.17-44.42-
Price-to-Total Gains Ratio5.67-85.49-16.63-37.43-254.16-385.49-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.073704
Number of shares13567
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.00
Usd Total Gains Per Share0.010.00
Gains per Quarter (13567 shares)85.0161.43
Gains per Year (13567 shares)340.04245.73
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
103403300246236
206806700491482
30102010100737728
40136013500983974
5017001690012291220
6020402030014741466
7023802370017201712
8027202710019661958
9030603050022122204
10034003390024572450

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%8.04.00.066.7%16.04.00.080.0%33.06.01.082.5%40.06.01.085.1%
Book Value Change Per Share4.00.00.0100.0%10.02.00.083.3%18.02.00.090.0%35.05.00.087.5%41.05.01.087.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.047.00.0%
Total Gains per Share4.00.00.0100.0%10.02.00.083.3%18.02.00.090.0%35.05.00.087.5%41.05.01.087.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of RTA Laboratuvarlari Biyolojik compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4970.252+98%0.405+23%0.256+94%0.182+173%0.094+429%
Book Value Per Share--3.8353.323+15%2.338+64%2.260+70%1.549+148%0.831+362%
Current Ratio--1.0491.128-7%2.569-59%2.230-53%2.105-50%2.781-62%
Debt To Asset Ratio--0.0930.127-27%0.141-34%0.150-38%0.182-49%0.170-45%
Debt To Equity Ratio--0.1030.146-30%0.180-43%0.187-45%0.288-64%0.240-57%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--1212895894.0005349788876.250-77%6395204450.500-81%5360220726.917-77%8793904941.750-86%5790277115.351-79%
Eps--0.4300.060+616%-0.080+119%0.044+881%0.046+829%0.025+1646%
Ev To Sales Ratio--5.80533.036-82%51.233-89%163.533-96%119.558-95%104.600-94%
Free Cash Flow Per Share--0.228-0.124+154%-0.132+158%-0.079+135%-0.054+124%-0.029+113%
Free Cash Flow To Equity Per Share--0.228-0.124+154%-0.138+161%-0.080+135%-0.046+120%-0.022+110%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%0.975+3%
Intrinsic Value_10Y_max--22.604----------
Intrinsic Value_10Y_min--1.059----------
Intrinsic Value_1Y_max--0.229----------
Intrinsic Value_1Y_min---0.247----------
Intrinsic Value_3Y_max--2.240----------
Intrinsic Value_3Y_min---0.442----------
Intrinsic Value_5Y_max--6.121----------
Intrinsic Value_5Y_min---0.304----------
Market Cap1480000000.000+5%1410000000.0005588750000.000-75%6593750000.000-79%5546666666.667-75%8945250000.000-84%5871255174.076-76%
Net Profit Margin--4.1160.440+836%-0.380+109%6.608-38%4.112+0%2.144+92%
Operating Margin----0%-0.0510%-1.2300%-0.6310%-0.3080%
Operating Ratio--1.7791.959-9%2.343-24%3.525-50%2.614-32%2.026-12%
Pb Ratio0.772+5%0.7353.505-79%6.084-88%5.847-87%33.169-98%44.424-98%
Pe Ratio1.721+5%1.640-6.274+483%-0.091+106%3.236-49%76.204-98%547.787-100%
Price Per Share2.960+5%2.82011.178-75%13.188-79%11.093-75%17.891-84%11.706-76%
Price To Free Cash Flow Ratio3.248+5%3.094-28.041+1006%-6.718+317%-13.084+523%-36.695+1286%-180.512+5934%
Price To Total Gains Ratio5.955+5%5.67485.494-93%16.631-66%37.434-85%254.163-98%385.489-99%
Quick Ratio--0.4790.379+27%1.103-57%1.071-55%1.014-53%1.334-64%
Return On Assets--0.1020.012+776%-0.025+125%0.033+211%0.056+82%0.038+165%
Return On Equity--0.1120.012+811%-0.040+136%0.039+185%0.073+55%0.049+128%
Total Gains Per Share--0.4970.252+98%0.405+23%0.256+94%0.182+173%0.094+429%
Usd Book Value--47745975.69441368343.723+15%29107770.691+64%28133629.113+70%19290480.430+148%10360126.376+361%
Usd Book Value Change Per Share--0.0120.006+98%0.010+23%0.006+94%0.005+173%0.002+429%
Usd Book Value Per Share--0.0950.083+15%0.058+64%0.056+70%0.039+148%0.021+362%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--30201107.761133209743.019-77%159240590.817-81%133469496.100-77%218968233.050-86%144177900.172-79%
Usd Eps--0.0110.001+616%-0.002+119%0.001+881%0.001+829%0.001+1646%
Usd Free Cash Flow--2836506.582-1538919.992+154%-1639723.727+158%-989550.869+135%-675328.751+124%-335978.057+112%
Usd Free Cash Flow Per Share--0.006-0.003+154%-0.003+158%-0.002+135%-0.001+124%-0.001+113%
Usd Free Cash Flow To Equity Per Share--0.006-0.003+154%-0.003+161%-0.002+135%-0.001+120%-0.001+110%
Usd Market Cap36852000.000+5%35109000.000139159875.000-75%164184375.000-79%138112000.000-75%222736725.000-84%146194253.834-76%
Usd Price Per Share0.074+5%0.0700.278-75%0.328-79%0.276-75%0.445-84%0.291-76%
Usd Profit--5352782.407747155.986+616%-992326.360+119%545897.406+881%576476.856+829%307052.320+1643%
Usd Revenue--1300562.1841068499.344+22%834023.415+56%754006.111+72%1243390.091+5%720179.180+81%
Usd Total Gains Per Share--0.0120.006+98%0.010+23%0.006+94%0.005+173%0.002+429%
 EOD+4 -4MRQTTM+25 -10YOY+24 -113Y+24 -115Y+25 -1010Y+26 -10

3.3 Fundamental Score

Let's check the fundamental score of RTA Laboratuvarlari Biyolojik based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-151.721
Price to Book Ratio (EOD)Between0-10.772
Net Profit Margin (MRQ)Greater than04.116
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.479
Current Ratio (MRQ)Greater than11.049
Debt to Asset Ratio (MRQ)Less than10.093
Debt to Equity Ratio (MRQ)Less than10.103
Return on Equity (MRQ)Greater than0.150.112
Return on Assets (MRQ)Greater than0.050.102
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of RTA Laboratuvarlari Biyolojik based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose2.910
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About RTA Laboratuvarlari Biyolojik

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. engages in the research, development, and production of microbiology and molecular biology products in Turkey. It offers microbiology products, including petri dish, tube and bottle, chromogenic media, blood culture bottle, tuberculosis diagnostic, rapid test, microbiological stain, hygislide, surcheck media, membrane, and swab products; and molecular biology products, such as nucleic acid isolation kits, real time PCR kits, and voltran viral load detection systems. The company was incorporated in 1996 and is based in Kocaeli, Turkey.

Fundamental data was last updated by Penke on 2025-07-02 12:16:07.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit RTA Laboratuvarlari Biyolojik earns for each ₤1 of revenue.

  • Above 10% is considered healthy but always compare RTA Laboratuvarlari Biyolojik to the Biotechnology industry mean.
  • A Net Profit Margin of 411.6% means that ₤4.12 for each ₤1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 411.6%. The company is making a huge profit. +2
  • The TTM is 44.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ411.6%TTM44.0%+367.6%
TTM44.0%YOY-38.0%+81.9%
TTM44.0%5Y411.2%-367.2%
5Y411.2%10Y214.4%+196.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ411.6%-91.7%+503.3%
TTM44.0%-140.3%+184.3%
YOY-38.0%-196.4%+158.4%
3Y660.8%-247.9%+908.7%
5Y411.2%-343.3%+754.5%
10Y214.4%-488.1%+702.5%
4.3.1.2. Return on Assets

Shows how efficient RTA Laboratuvarlari Biyolojik is using its assets to generate profit.

  • Above 5% is considered healthy but always compare RTA Laboratuvarlari Biyolojik to the Biotechnology industry mean.
  • 10.2% Return on Assets means that RTA Laboratuvarlari Biyolojik generated ₤0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 10.2%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 1.2%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ10.2%TTM1.2%+9.0%
TTM1.2%YOY-2.5%+3.7%
TTM1.2%5Y5.6%-4.4%
5Y5.6%10Y3.8%+1.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.2%-11.5%+21.7%
TTM1.2%-11.5%+12.7%
YOY-2.5%-11.4%+8.9%
3Y3.3%-11.7%+15.0%
5Y5.6%-11.9%+17.5%
10Y3.8%-13.7%+17.5%
4.3.1.3. Return on Equity

Shows how efficient RTA Laboratuvarlari Biyolojik is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare RTA Laboratuvarlari Biyolojik to the Biotechnology industry mean.
  • 11.2% Return on Equity means RTA Laboratuvarlari Biyolojik generated ₤0.11 for each ₤1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 11.2%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 1.2%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ11.2%TTM1.2%+10.0%
TTM1.2%YOY-4.0%+5.2%
TTM1.2%5Y7.3%-6.0%
5Y7.3%10Y4.9%+2.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.2%-13.6%+24.8%
TTM1.2%-14.8%+16.0%
YOY-4.0%-14.4%+10.4%
3Y3.9%-16.8%+20.7%
5Y7.3%-17.5%+24.8%
10Y4.9%-19.5%+24.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of RTA Laboratuvarlari Biyolojik.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient RTA Laboratuvarlari Biyolojik is operating .

  • Measures how much profit RTA Laboratuvarlari Biyolojik makes for each ₤1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare RTA Laboratuvarlari Biyolojik to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ₤0.00  for each ₤1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-5.1%+5.1%
TTM-5Y-63.1%+63.1%
5Y-63.1%10Y-30.8%-32.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--221.8%+221.8%
TTM--250.7%+250.7%
YOY-5.1%-208.5%+203.4%
3Y-123.0%-220.2%+97.2%
5Y-63.1%-342.4%+279.3%
10Y-30.8%-462.5%+431.7%
4.3.2.2. Operating Ratio

Measures how efficient RTA Laboratuvarlari Biyolojik is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.78 means that the operating costs are ₤1.78 for each ₤1 in net sales.

Let's take a look of the Operating Ratio trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 1.779. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.959. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.779TTM1.959-0.181
TTM1.959YOY2.343-0.383
TTM1.9595Y2.614-0.655
5Y2.61410Y2.026+0.588
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7792.097-0.318
TTM1.9592.684-0.725
YOY2.3433.076-0.733
3Y3.5253.524+0.001
5Y2.6144.724-2.110
10Y2.0266.445-4.419
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of RTA Laboratuvarlari Biyolojik.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if RTA Laboratuvarlari Biyolojik is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.05 means the company has ₤1.05 in assets for each ₤1 in short-term debts.

Let's take a look of the Current Ratio trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 1.049. The company is just able to pay all its short-term debts.
  • The TTM is 1.128. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.049TTM1.128-0.078
TTM1.128YOY2.569-1.441
TTM1.1285Y2.105-0.977
5Y2.10510Y2.781-0.677
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0493.638-2.589
TTM1.1283.846-2.718
YOY2.5694.140-1.571
3Y2.2304.688-2.458
5Y2.1055.722-3.617
10Y2.7816.144-3.363
4.4.3.2. Quick Ratio

Measures if RTA Laboratuvarlari Biyolojik is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare RTA Laboratuvarlari Biyolojik to the Biotechnology industry mean.
  • A Quick Ratio of 0.48 means the company can pay off ₤0.48 for each ₤1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 0.479. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.379. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.479TTM0.379+0.101
TTM0.379YOY1.103-0.724
TTM0.3795Y1.014-0.636
5Y1.01410Y1.334-0.320
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4792.826-2.347
TTM0.3793.116-2.737
YOY1.1033.786-2.683
3Y1.0714.311-3.240
5Y1.0145.702-4.688
10Y1.3346.335-5.001
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of RTA Laboratuvarlari Biyolojik.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of RTA Laboratuvarlari Biyolojik assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare RTA Laboratuvarlari Biyolojik to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.09 means that RTA Laboratuvarlari Biyolojik assets are financed with 9.3% credit (debt) and the remaining percentage (100% - 9.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 0.093. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.127. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.093TTM0.127-0.034
TTM0.127YOY0.141-0.015
TTM0.1275Y0.182-0.055
5Y0.18210Y0.170+0.013
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0930.327-0.234
TTM0.1270.349-0.222
YOY0.1410.332-0.191
3Y0.1500.340-0.190
5Y0.1820.346-0.164
10Y0.1700.378-0.208
4.5.4.2. Debt to Equity Ratio

Measures if RTA Laboratuvarlari Biyolojik is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare RTA Laboratuvarlari Biyolojik to the Biotechnology industry mean.
  • A Debt to Equity ratio of 10.3% means that company has ₤0.10 debt for each ₤1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 0.103. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.146. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.103TTM0.146-0.044
TTM0.146YOY0.180-0.034
TTM0.1465Y0.288-0.141
5Y0.28810Y0.240+0.047
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1030.383-0.280
TTM0.1460.438-0.292
YOY0.1800.414-0.234
3Y0.1870.450-0.263
5Y0.2880.457-0.169
10Y0.2400.512-0.272
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₤1 in earnings RTA Laboratuvarlari Biyolojik generates.

  • Above 15 is considered overpriced but always compare RTA Laboratuvarlari Biyolojik to the Biotechnology industry mean.
  • A PE ratio of 1.64 means the investor is paying ₤1.64 for every ₤1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of RTA Laboratuvarlari Biyolojik:

  • The EOD is 1.721. Based on the earnings, the company is cheap. +2
  • The MRQ is 1.640. Based on the earnings, the company is cheap. +2
  • The TTM is -6.274. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD1.721MRQ1.640+0.081
MRQ1.640TTM-6.274+7.914
TTM-6.274YOY-0.091-6.183
TTM-6.2745Y76.204-82.479
5Y76.20410Y547.787-471.583
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.721-2.399+4.120
MRQ1.640-2.092+3.732
TTM-6.274-2.625-3.649
YOY-0.091-3.784+3.693
3Y3.236-3.762+6.998
5Y76.204-6.363+82.567
10Y547.787-7.055+554.842
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of RTA Laboratuvarlari Biyolojik:

  • The EOD is 3.248. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 3.094. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -28.041. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD3.248MRQ3.094+0.154
MRQ3.094TTM-28.041+31.136
TTM-28.041YOY-6.718-21.323
TTM-28.0415Y-36.695+8.654
5Y-36.69510Y-180.512+143.818
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.248-3.299+6.547
MRQ3.094-2.742+5.836
TTM-28.041-3.801-24.240
YOY-6.718-4.402-2.316
3Y-13.084-5.140-7.944
5Y-36.695-8.483-28.212
10Y-180.512-9.296-171.216
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of RTA Laboratuvarlari Biyolojik is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.74 means the investor is paying ₤0.74 for each ₤1 in book value.

Let's take a look of the Price to Book Ratio trends of RTA Laboratuvarlari Biyolojik:

  • The EOD is 0.772. Based on the equity, the company is cheap. +2
  • The MRQ is 0.735. Based on the equity, the company is cheap. +2
  • The TTM is 3.505. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD0.772MRQ0.735+0.037
MRQ0.735TTM3.505-2.770
TTM3.505YOY6.084-2.580
TTM3.5055Y33.169-29.664
5Y33.16910Y44.424-11.255
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.7722.113-1.341
MRQ0.7351.856-1.121
TTM3.5052.125+1.380
YOY6.0842.454+3.630
3Y5.8472.492+3.355
5Y33.1693.668+29.501
10Y44.4244.364+40.060
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in TRY. All numbers in thousands.

Summary
Total Assets2,114,613
Total Liabilities197,104
Total Stockholder Equity1,917,509
 As reported
Total Liabilities 197,104
Total Stockholder Equity+ 1,917,509
Total Assets = 2,114,613

Assets

Total Assets2,114,613
Total Current Assets174,925
Long-term Assets1,939,688
Total Current Assets
Cash And Cash Equivalents 6,123
Short-term Investments 4,759
Net Receivables 75,152
Inventory 40,761
Other Current Assets 5
Total Current Assets  (as reported)174,925
Total Current Assets  (calculated)126,800
+/- 48,125
Long-term Assets
Property Plant Equipment 310,325
Intangible Assets 85
Long-term Assets  (as reported)1,939,688
Long-term Assets  (calculated)310,411
+/- 1,629,278

Liabilities & Shareholders' Equity

Total Current Liabilities166,682
Long-term Liabilities30,422
Total Stockholder Equity1,917,509
Total Current Liabilities
Short Long Term Debt 134,050
Accounts payable 22,184
Other Current Liabilities 52
Total Current Liabilities  (as reported)166,682
Total Current Liabilities  (calculated)156,286
+/- 10,397
Long-term Liabilities
Long term Debt 23,653
Capital Lease Obligations Min Short Term Debt4,915
Long-term Liabilities  (as reported)30,422
Long-term Liabilities  (calculated)28,568
+/- 1,853
Total Stockholder Equity
Retained Earnings 991,164
Total Stockholder Equity (as reported)1,917,509
Total Stockholder Equity (calculated)991,164
+/- 926,345
Other
Capital Stock500,000
Common Stock Shares Outstanding 500,000
Net Debt 151,581
Net Invested Capital 2,075,212
Net Working Capital 8,242
Property Plant and Equipment Gross 492,358



6.2. Balance Sheets Structured

Currency in TRY. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-03-312012-12-312011-12-312010-12-31
> Total Assets 
16,857
16,604
20,450
0
29,352
29,409
40,368
45,782
49,042
52,462
54,155
54,642
60,756
60,758
61,103
58,354
60,893
64,259
64,076
63,345
63,092
61,439
61,093
62,075
65,640
66,353
71,123
82,008
98,160
127,310
181,568
212,054
256,525
319,067
161,739
501,067
552,404
541,113
558,881
690,060
740,213
735,081
832,569
1,022,946
1,804,552
1,810,062
1,817,726
1,747,855
1,921,167
2,114,613
2,114,6131,921,1671,747,8551,817,7261,810,0621,804,5521,022,946832,569735,081740,213690,060558,881541,113552,404501,067161,739319,067256,525212,054181,568127,31098,16082,00871,12366,35365,64062,07561,09361,43963,09263,34564,07664,25960,89358,35461,10360,75860,75654,64254,15552,46249,04245,78240,36829,40929,352020,45016,60416,857
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
41,317
41,098
40,847
37,917
36,504
36,674
32,864
31,994
14,876
23,621
34,561
59,666
103,684
120,176
142,975
194,043
222,304
323,087
369,387
326,440
297,312
317,029
300,531
288,269
281,423
252,229
249,155
184,419
206,861
184,365
155,035
174,925
174,925155,035184,365206,861184,419249,155252,229281,423288,269300,531317,029297,312326,440369,387323,087222,304194,043142,975120,176103,68459,66634,56123,62114,87631,99432,86436,67436,50437,91740,84741,09841,317000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,756
13,037
15,124
13,159
16,142
11,404
6,141
3,561
633
842
12,379
23,057
11,689
1,107
15,662
4,828
52,487
70,121
157,539
71,567
24,028
62,929
31,363
157,120
38,751
88,380
32,664
13,208
13,032
13,116
6,512
6,123
6,1236,51213,11613,03213,20832,66488,38038,751157,12031,36362,92924,02871,567157,53970,12152,4874,82815,6621,10711,68923,05712,3798426333,5616,14111,40416,14213,15915,12413,03713,756000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,326
3,490
9,432
0
0
41
0
0
9,544
3,241
1,372
917
868
264
270
5,863
313
6,731
15,244
118,082
1,147
111,933
50,852
70,096
540
545
541
4,471
4,759
4,7594,47154154554070,09650,852111,9331,147118,08215,2446,7313135,8632702648689171,3723,2419,5440041009,4323,4905,326000000000000000000000
       Net Receivables 
4,575
4,649
7,204
0
5,509
6,451
6,991
7,574
7,847
8,359
7,443
7,982
9,101
8,988
7,929
7,687
9,872
10,707
12,300
12,656
14,893
9,978
8,539
8,247
18,515
8,713
7,472
6,805
16,310
16,522
31,290
37,277
76,582
134,962
102,746
171,139
141,272
200,247
204,353
169,909
92,770
74,925
55,857
32,798
42,199
45,578
49,165
55,855
60,296
75,152
75,15260,29655,85549,16545,57842,19932,79855,85774,92592,770169,909204,353200,247141,272171,139102,746134,96276,58237,27731,29016,52216,3106,8057,4728,71318,5158,2478,5399,97814,89312,65612,30010,7079,8727,6877,9298,9889,1017,9827,4438,3597,8477,5746,9916,4515,50907,2044,6494,575
       Other Current Assets 
512
628
863
0
800
553
1,273
1,981
1,419
2,455
1,725
2,168
4,849
3,210
2,685
3,568
2,916
2,504
2,365
2,300
2,410
3,461
1,585
1,893
3,984
2,333
0
4
2,763
6,502
17,173
15,813
21,661
25,266
26,200
26,599
26,584
25,028
33,628
31,067
30,309
17,474
41,203
25
283
11
8
16
3
5
53168112832541,20317,47430,30931,06733,62825,02826,58426,59926,20025,26621,66115,81317,1736,5022,763402,3333,9841,8931,5853,4612,4102,3002,3652,5042,9163,5682,6853,2104,8492,1681,7252,4551,4191,9811,2735538000863628512
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,359
56,247
58,387
63,600
67,644
77,884
91,878
113,550
125,024
165,259
177,979
183,017
214,673
261,569
373,031
439,682
446,812
551,147
770,717
1,034,798
1,625,643
1,610,866
1,563,490
1,766,132
1,939,688
1,939,6881,766,1321,563,4901,610,8661,625,6431,034,798770,717551,147446,812439,682373,031261,569214,673183,017177,979165,259125,024113,55091,87877,88467,64463,60058,38756,24734,3590000000000000000000000000
       Property Plant Equipment 
2,191
1,836
3,237
0
8,061
8,071
8,113
8,467
8,246
9,174
9,679
10,181
9,818
9,954
16,786
16,745
11,616
11,400
9,882
9,523
9,482
9,550
9,651
10,297
11,167
11,444
0
15,116
14,781
15,157
15,714
22,165
31,399
34,636
40,300
43,705
46,754
48,488
48,342
54,149
53,680
49,052
50,636
57,166
146,468
163,535
180,901
226,040
286,325
310,325
310,325286,325226,040180,901163,535146,46857,16650,63649,05253,68054,14948,34248,48846,75443,70540,30034,63631,39922,16515,71415,15714,78115,116011,44411,16710,2979,6519,5509,4829,5239,88211,40011,61616,74516,7869,9549,81810,1819,6799,1748,2468,4678,1138,0718,06103,2371,8362,191
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,031
1,031
1,031
1,031
1,031
1,031
1,031
1,031
1,031
1,031
1,031
1,031
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000001,0311,0311,0311,0311,0311,0311,0311,0311,0311,0311,0311,03100000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22,891
28,193
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000028,19322,891000000000000000000000000000
       Intangible Assets 
357
1,047
1,127
0
808
784
682
729
680
1,022
998
998
7,424
7,237
1,145
1,123
1,084
1,080
1,077
1,078
1,088
1,956
2,045
2,394
57
685
610
541
477
498
587
709
760
710
649
620
564
535
506
477
449
164
147
130
302
279
238
191
131
85
85131191238279302130147164449477506535564620649710760709587498477541610685572,3942,0451,9561,0881,0781,0771,0801,0841,1231,1457,2377,4249989981,02268072968278480801,1271,047357
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,359
56,247
58,387
63,600
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000063,60058,38756,24734,3590000000000000000000000000
> Total Liabilities 
5,393
6,412
9,459
0
8,519
7,738
4,645
9,434
11,399
12,452
12,386
11,788
15,279
13,588
11,729
9,768
10,690
12,973
11,875
10,165
8,841
6,470
6,167
7,005
6,955
5,736
6,179
4,849
11,466
28,312
50,418
65,193
88,719
122,529
-77,917
172,491
209,170
158,947
118,357
131,538
107,473
129,956
121,077
113,135
164,132
395,838
306,279
200,292
252,170
197,104
197,104252,170200,292306,279395,838164,132113,135121,077129,956107,473131,538118,357158,947209,170172,491-77,917122,52988,71965,19350,41828,31211,4664,8496,1795,7366,9557,0056,1676,4708,84110,16511,87512,97310,6909,76811,72913,58815,27911,78812,38612,45211,3999,4344,6457,7388,51909,4596,4125,393
   > Total Current Liabilities 
4,987
6,062
8,963
0
7,043
6,220
3,211
7,541
9,725
10,208
10,047
9,239
10,386
11,406
9,987
8,250
9,278
11,596
10,788
9,316
8,264
6,146
5,682
6,651
6,625
5,425
2,797
1,602
7,808
23,679
45,675
60,418
82,514
116,527
143,165
171,346
204,880
133,905
97,276
110,701
88,585
108,572
94,524
82,683
88,819
127,879
129,150
161,802
215,068
166,682
166,682215,068161,802129,150127,87988,81982,68394,524108,57288,585110,70197,276133,905204,880171,346143,165116,52782,51460,41845,67523,6797,8081,6022,7975,4256,6256,6515,6826,1468,2649,31610,78811,5969,2788,2509,98711,40610,3869,23910,04710,2089,7257,5413,2116,2207,04308,9636,0624,987
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,492
146
107
67
24
0
0
539
0
88
6,109
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000006,1098805390024671071461,492000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,492
146
107
67
24
0
0
539
0
88
6,109
9,684
15,123
16,860
21,910
0
835
46,242
55,121
56,552
26,620
67,834
67,076
79,213
71,007
51,226
43,556
14,640
73,672
135,715
188,426
134,050
134,050188,426135,71573,67214,64043,55651,22671,00779,21367,07667,83426,62056,55255,12146,242835021,91016,86015,1239,6846,1098805390024671071461,492000000000000000000
       Accounts payable 
2,254
3,894
5,234
0
5,530
5,002
1,636
5,063
7,573
8,359
7,528
5,999
6,170
7,781
5,941
5,562
5,902
8,496
7,692
5,918
4,843
3,717
3,565
4,854
5,260
3,893
2,144
1,166
1,438
2,096
16,507
23,184
23,517
50,086
32,282
83,153
101,272
52,326
17,745
16,656
11,149
15,704
12,317
18,981
34,799
30,931
44,261
20,330
20,444
22,184
22,18420,44420,33044,26130,93134,79918,98112,31715,70411,14916,65617,74552,326101,27283,15332,28250,08623,51723,18416,5072,0961,4381,1662,1443,8935,2604,8543,5653,7174,8435,9187,6928,4965,9025,5625,9417,7816,1705,9997,5288,3597,5735,0631,6365,0025,53005,2343,8942,254
       Other Current Liabilities 
1,791
1,176
2,412
0
1,505
1,162
1,473
2,353
1,897
1,654
2,195
2,995
4,190
1,203
1,750
1,373
1,848
1,197
1,635
1,843
1,935
1,188
323
250
113
260
165
25
83
11,548
13,615
19,846
29,921
18,690
68,734
36,477
45,750
23,972
23,646
23,741
8,796
11,185
9,033
78
0
13
0
0
0
52
52000130789,03311,1858,79623,74123,64623,97245,75036,47768,73418,69029,92119,84613,61511,54883251652601132503231,1881,9351,8431,6351,1971,8481,3731,7501,2034,1902,9952,1951,6541,8972,3531,4731,1621,50502,4121,1761,791
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
311
3,383
3,247
3,657
4,633
4,743
4,775
6,204
6,002
-221,082
1,145
4,289
25,042
21,081
20,837
18,888
21,384
26,554
30,452
75,312
267,959
177,129
38,490
37,102
30,422
30,42237,10238,490177,129267,95975,31230,45226,55421,38418,88820,83721,08125,0424,2891,145-221,0826,0026,2044,7754,7434,6333,6573,2473,3833110000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,492
-146
-107
-67
-24
0
0
-539
0
-88
-6,109
0
138
203
985
0
0
632
528
205
991
866
1,183
746
692
636
2,167
2,072
5,259
0
5,480
4,915
4,9155,48005,2592,0722,1676366927461,183866991205528632009852031380-6,109-880-53900-24-67-107-146-1,492000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,156
1,054
954
0
0
0
630
561
0
421
357
301
241
175
104
37
-31
0
0
0
-36
0
0
0
0
0
0
0
0
0
0
0
00000000000-36000-313710417524130135742105616300009541,0541,156000000000000000000
> Total Stockholder Equity
11,848
10,991
11,875
10,991
20,833
21,671
35,722
35,480
36,726
39,092
40,974
41,996
44,585
46,377
48,868
48,113
49,922
51,097
52,038
53,067
54,171
54,971
54,903
55,443
59,536
61,316
64,944
77,159
86,628
97,122
123,571
137,623
150,275
174,750
211,461
299,567
312,674
344,920
403,690
521,643
594,521
605,125
711,492
909,810
1,119,821
1,414,224
1,511,448
1,547,563
1,668,997
1,917,509
1,917,5091,668,9971,547,5631,511,4481,414,2241,119,821909,810711,492605,125594,521521,643403,690344,920312,674299,567211,461174,750150,275137,623123,57197,12286,62877,15964,94461,31659,53655,44354,90354,97154,17153,06752,03851,09749,92248,11348,86846,37744,58541,99640,97439,09236,72635,48035,72221,67120,83310,99111,87510,99111,848
   Common Stock
4,800
4,800
4,800
0
4,800
4,800
5,900
5,900
5,900
5,900
5,900
5,900
5,900
5,900
5,900
5,900
5,900
5,900
23,600
23,600
23,600
23,600
23,600
23,600
23,600
23,600
0
36,100
36,100
41,000
41,000
41,000
41,000
41,000
41,000
42,970
42,970
42,970
100,000
100,000
100,000
100,000
100,000
0
0
0
0
0
0
0
0000000100,000100,000100,000100,000100,00042,97042,97042,97041,00041,00041,00041,00041,00041,00036,10036,100023,60023,60023,60023,60023,60023,60023,60023,6005,9005,9005,9005,9005,9005,9005,9005,9005,9005,9005,9005,9004,8004,80004,8004,8004,800
   Retained Earnings 
5,699
4,454
6,031
0
11,575
12,966
14,070
15,084
16,183
18,273
20,225
22,298
23,971
25,551
25,656
24,971
26,902
28,031
23,371
24,448
25,618
25,655
25,711
26,263
27,774
29,549
31,892
31,504
32,228
41,200
67,675
81,780
93,161
117,642
154,359
194,543
207,634
239,900
272,702
390,637
463,841
474,445
580,812
776,083
536,759
743,716
755,256
755,217
827,200
991,164
991,164827,200755,217755,256743,716536,759776,083580,812474,445463,841390,637272,702239,900207,634194,543154,359117,64293,16181,78067,67541,20032,22831,50431,89229,54927,77426,26325,71125,65525,61824,44823,37128,03126,90224,97125,65625,55123,97122,29820,22518,27316,18315,08414,07012,96611,57506,0314,4545,699
   Capital Surplus 00000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000-94-94-94000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,067
5,019
4,952
5,716
5,593
5,580
8,161
8,168
0
8,084
18,230
7,991
7,964
7,912
9,183
9,177
9,171
9,177
9,192
9,173
9,173
9,191
8,865
8,865
8,865
0
0
0
0
0
0
0
00000008,8658,8658,8659,1919,1739,1739,1929,1779,1719,1779,1837,9127,9647,99118,2308,08408,1688,1615,5805,5935,7164,9525,0195,067000000000000000000



6.3. Balance Sheets

Currency in TRY. All numbers in thousands.




6.4. Cash Flows

Currency in TRY. All numbers in thousands.




6.5. Income Statements

Currency in TRY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in TRY. All numbers in thousands.

Gross Profit (+$)
totalRevenue158,590
Cost of Revenue-116,481
Gross Profit42,10942,109
 
Operating Income (+$)
Gross Profit42,109
Operating Expense-200,795
Operating Income-42,205-158,685
 
Operating Expense (+$)
Research Development22,191
Selling General Administrative16,273
Selling And Marketing Expenses0
Operating Expense200,79538,464
 
Net Interest Income (+$)
Interest Income8,131
Interest Expense-78,003
Other Finance Cost-189
Net Interest Income-70,062
 
Pretax Income (+$)
Operating Income-42,205
Net Interest Income-70,062
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-51,663-42,205
EBIT - interestExpense = -78,003
52,235
130,238
Interest Expense78,003
Earnings Before Interest and Taxes (EBIT)026,341
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-51,663
Tax Provision--103,898
Net Income From Continuing Ops52,23552,235
Net Income52,235
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net070,062
 

Technical Analysis of RTA Laboratuvarlari Biyolojik
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of RTA Laboratuvarlari Biyolojik. The general trend of RTA Laboratuvarlari Biyolojik is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine RTA Laboratuvarlari Biyolojik's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. RTA Laboratuvarlari Biyolojik Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of RTA Laboratuvarlari Biyolojik.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 3.03 < 3.21 < 3.33.

The bearish price targets are: 2.93 > 2.6 > 2.6.

Know someone who trades $RTALB? Share this with them.👇

RTA Laboratuvarlari Biyolojik Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of RTA Laboratuvarlari Biyolojik. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

RTA Laboratuvarlari Biyolojik Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of RTA Laboratuvarlari Biyolojik.

RTA Laboratuvarlari Biyolojik Daily Moving Average Convergence/Divergence (MACD) ChartRTA Laboratuvarlari Biyolojik Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of RTA Laboratuvarlari Biyolojik. The current adx is .

RTA Laboratuvarlari Biyolojik Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of RTA Laboratuvarlari Biyolojik.

RTA Laboratuvarlari Biyolojik Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of RTA Laboratuvarlari Biyolojik.

RTA Laboratuvarlari Biyolojik Daily Relative Strength Index (RSI) ChartRTA Laboratuvarlari Biyolojik Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of RTA Laboratuvarlari Biyolojik.

RTA Laboratuvarlari Biyolojik Daily Stochastic Oscillator ChartRTA Laboratuvarlari Biyolojik Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of RTA Laboratuvarlari Biyolojik.

RTA Laboratuvarlari Biyolojik Daily Commodity Channel Index (CCI) ChartRTA Laboratuvarlari Biyolojik Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of RTA Laboratuvarlari Biyolojik.

RTA Laboratuvarlari Biyolojik Daily Chande Momentum Oscillator (CMO) ChartRTA Laboratuvarlari Biyolojik Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of RTA Laboratuvarlari Biyolojik.

RTA Laboratuvarlari Biyolojik Daily Williams %R ChartRTA Laboratuvarlari Biyolojik Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of RTA Laboratuvarlari Biyolojik.

RTA Laboratuvarlari Biyolojik Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of RTA Laboratuvarlari Biyolojik.

RTA Laboratuvarlari Biyolojik Daily Average True Range (ATR) ChartRTA Laboratuvarlari Biyolojik Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of RTA Laboratuvarlari Biyolojik.

RTA Laboratuvarlari Biyolojik Daily On-Balance Volume (OBV) ChartRTA Laboratuvarlari Biyolojik Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of RTA Laboratuvarlari Biyolojik.

RTA Laboratuvarlari Biyolojik Daily Money Flow Index (MFI) ChartRTA Laboratuvarlari Biyolojik Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for RTA Laboratuvarlari Biyolojik.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-03-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-17MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-18STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-05-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-05-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-05-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-23BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

RTA Laboratuvarlari Biyolojik Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of RTA Laboratuvarlari Biyolojik based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose2.910
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of RTA Laboratuvarlari Biyolojik with someone you think should read this too:
  • Are you bullish or bearish on RTA Laboratuvarlari Biyolojik? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about RTA Laboratuvarlari Biyolojik? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about RTA Laboratuvarlari Biyolojik

I send you an email if I find something interesting about RTA Laboratuvarlari Biyolojik.


Comments

How you think about this?

Leave a comment

Stay informed about RTA Laboratuvarlari Biyolojik.

Receive notifications about RTA Laboratuvarlari Biyolojik in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.